CTLA4 and Merkel cell skin cancer: It was obtained from a patient with metastatic Merkel cell carcinoma, treated using T cell immunotherapy as well as immune-checkpoint inhibitors (anti-PD1 and anti-CTLA4) but later developed resistance [13].